Related Experiment Video
Updated: Aug 26, 2026

Apoplast-Extraction Based Method to Improve the Purity of Plant Produced Recombinant Protein
Published on: July 5, 2024
Plant-based production of biopharmaceuticals
Rainer Fischer1, Eva Stoger, Stefan Schillberg
1Institute for Molecular Biotechnology, Biology VII, RWTH Aachen, Worringerweg 1, 52074 Aachen, Germany.
Abstract:
Plants are now gaining widespread acceptance as a general platform for the large-scale production of recombinant proteins. The first plant-derived recombinant pharmaceutical proteins are reaching the final stages of clinical evaluation, and many more are in the development pipeline. Over the past two years, there have been some notable technological advances in this flourishing area of applied biotechnology, as shown by the continuing commercial development of novel plant-based expression platforms. There has also been significant success in tackling some of the limitations of plant bioreactors, such as low yields and inconsistent product quality, that have limited the approval of plant-derived pharmaceuticals.
More Related Videos
Related Concept Videos
Production of Pharmaceuticals
Upstream Processing
Bioplastics
Production of Antibiotics
Vaccine Production
Drug Products: Biologics, Biosimilars and Interchangeables

